Literature DB >> 11507749

A comprehensive on-line digestion-liquid chromatography/mass spectrometry/collision-induced dissociation mass spectrometry approach for the characterization of human fibrinogen.

G Vecchione1, B Casetta, R Santacroce, M Margaglione.   

Abstract

An automatic on-line digestion-liquid chromatography/mass spectrometry/collision-induced dissociation mass spectrometry (LC-MS/CID-MS) protocol has been developed for detection of errors in the biosynthesis of human fibrinogen, such as amino acid (AA) mismatch or incorrect post-translational modification (PTM). Using on-line digestion on an immobilized-enzyme column, the reaction time is significantly reduced (less than 20 min) and the entire approach is suitable for automation. The two-loop MS experiments (full-scan acquisition and sugar moieties monitoring by SIM) allow checking both the correct AA mapping via the peptides generated by the digestion of the PTM. Since the protocol was designed for application on a routine basis, as a proof-of-concept detection of a rare case of 'abnormal' fibrinogen has been demonstrated. The advantage of the proposed approach is exemplified by the fact that the DNA sequence information for the case investigated had not shown any evidence of the abnormality. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507749     DOI: 10.1002/rcm.355

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  2 in total

1.  Automated, rapid solid-phase proteolytic cleavage and sample preparation for proteomics.

Authors:  Pavel Metalnikov; Paul O'Donnel; Galina Vassilovski; Keith Ashman
Journal:  J Biomol Tech       Date:  2002-06

2.  Performance comparison of three trypsin columns used in liquid chromatography.

Authors:  Tereza Šlechtová; Martin Gilar; Květa Kalíková; Stephanie M Moore; James W Jorgenson; Eva Tesařová
Journal:  J Chromatogr A       Date:  2017-02-14       Impact factor: 4.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.